Valdivieso M - Search Results

1

Phase II study of hyperfractionated radiotherapy and concurrent weekly alternating chemotherapy in limited-stage small cell lung cancer.

Ali MA, Kraut MJ, Valdivieso M, Herskovic AM, Du W, Kalemkerian GP. Ali MA, et al. Among authors: valdivieso m. Lung Cancer. 1998 Oct;22(1):39-44. doi: 10.1016/s0169-5002(98)00064-6. Lung Cancer. 1998. PMID: 9869106 Clinical Trial.

2

Phase II Trial of Dose-dense Pemetrexed, Gemcitabine, and Bevacizumab in Patients With Advanced, Non-Small-cell Lung Cancer.

Schneider BJ, Kalemkerian GP, Gadgeel SM, Valdivieso M, Hackstock DM, Chen W, Heilbrun LK, Ruckdeschel JC, Wozniak AJ. Schneider BJ, et al. Among authors: valdivieso m. Clin Lung Cancer. 2017 May;18(3):299-302. doi: 10.1016/j.cllc.2016.11.019. Epub 2016 Dec 2. Clin Lung Cancer. 2017. PMID: 28063799 Free PMC article. Clinical Trial.

3

5-Fluorouracil, etoposide, and cisplatin in the management of metastatic non-small cell lung cancer.

Flaherty L, Wozniak A, Redman B, Kraut M, Martino S, Heilbrun L, Valdivieso M. Flaherty L, et al. Among authors: valdivieso m. Cancer. 1991 Sep 1;68(5):944-7. doi: 10.1002/1097-0142(19910901)68:5<944::aid-cncr2820680506>3.0.co;2-g. Cancer. 1991. PMID: 1655218 Clinical Trial.

4

A phase II study of dacarbazine and cisplatin in combination with outpatient administered interleukin-2 in metastatic malignant melanoma.

Flaherty LE, Robinson W, Redman BG, Gonzalez R, Martino S, Kraut M, Valdivieso M, Rudolph AR. Flaherty LE, et al. Among authors: valdivieso m. Cancer. 1993 Jun 1;71(11):3520-5. doi: 10.1002/1097-0142(19930601)71:11<3520::aid-cncr2820711110>3.0.co;2-a. Cancer. 1993. PMID: 8490900 Clinical Trial.

5

Phase I trial of concurrent thoracic radiation and continuous infusion cisplatin and etoposide in stage III non-small cell lung cancer.

Kalemkerian GP, Belzer K, Wozniak AJ, Gaspar LE, Valdivieso M, Kraut MJ. Kalemkerian GP, et al. Among authors: valdivieso m. Lung Cancer. 1999 Sep;25(3):175-82. doi: 10.1016/s0169-5002(99)00060-4. Lung Cancer. 1999. PMID: 10512128 Clinical Trial.

6

Etoposide-induced pulmonary toxicity.

Gurjal A, An T, Valdivieso M, Kalemkerian GP. Gurjal A, et al. Among authors: valdivieso m. Lung Cancer. 1999 Nov;26(2):109-12. doi: 10.1016/s0169-5002(99)00081-1. Lung Cancer. 1999. PMID: 10568682

7

A phase II study of mitomycin C, etoposide, and cisplatin in advanced non-small cell lung cancer.

Ali MA, Kraut MJ, Valdivieso M, Wozniak AJ, Cummings G, Kalemkerian GP. Ali MA, et al. Among authors: valdivieso m. Cancer Invest. 2000;18(1):1-5. doi: 10.3109/07357900009023055. Cancer Invest. 2000. PMID: 10701360 Clinical Trial.

8

A phase II study of weekly alternating chemotherapy in extensive-stage small cell lung cancer.

Kalemkerian GP, Ali MA, Luthra K, Wozniak AJ, Valdivieso M, Kraut MJ. Kalemkerian GP, et al. Among authors: valdivieso m. Cancer Invest. 2001;19(3):234-8. doi: 10.1081/cnv-100102549. Cancer Invest. 2001. PMID: 11338879 Clinical Trial.

9

Phase II study of deoxydoxorubicin in previously untreated metastatic breast cancer.

Martino S, Samal BA, Redman B, Flaherty L, Kraut M, Simon M, Valdivieso M. Martino S, et al. Among authors: valdivieso m. Breast Cancer Res Treat. 1990 Dec;17(2):139-43. doi: 10.1007/BF01806294. Breast Cancer Res Treat. 1990. PMID: 2096991 Clinical Trial.

10

A phase I trial of recombinant interleukin-2 combined with recombinant interferon-gamma in patients with cancer.

Redman BG, Flaherty L, Chou TH, al-Katib A, Kraut M, Martino S, Chen B, Kaplan J, Valdivieso M. Redman BG, et al. Among authors: valdivieso m. J Clin Oncol. 1990 Jul;8(7):1269-76. doi: 10.1200/JCO.1990.8.7.1269. J Clin Oncol. 1990. PMID: 2113571

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

238 results

Search Page

Filters